Acarix CADScor System now listed on US Federal Supply Schedule
Acarix, a leader in advanced acoustic and algorithm based cardiac diagnostic devices today announces that its CADScor System has been a...
NOTICE OF EXTRA GENERAL MEETING IN ACARIX AB
The shareholders of Acarix AB, reg. no. 559009-0667 (the "Company"), are hereby invited to the extra general meeting on Wednesday 21 Fe...
Acarix carries out a directed share issue of approximately SEK 33.7 million
THIS PRESS RELEASE IS NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BE...
Acarix appoints Aamir Mahmood as new CEO
Stockholm, Sweden, Feb 1, 2024 - The Board of Acarix AB (publ) announces today the appointment of Aamir Mahmood as new CEO with immedia...
Acarix strengthens US sales leadership team
Acarix, a leader in advanced acoustic-based cardiac diagnostics, announces a new US sales structure that aims to further strengthen its...
Acarix changes Certified Adviser to Carnegie Investment Bank AB (publ)
Acarix, a leader in advanced acoustic-based cardiac diagnostics, today announces a change of Certified Adviser from Erik Penser Bank AB...
Southeast Louisiana VA Healthcare System Reorders CADScor Patches
Acarix, a leader in advanced acoustic-based cardiac diagnostics, today announces an advancement in the utilization of its CADScor® ...
ACARIX CARRIES OUT A DIRECTED ISSUE TO GUARANTORS FOLLOWING THE COMPLETED RIGHTS ISSUE
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, HONG ...
Acarix AB (publ) publishes Interim Report, July – September 2023
Continued momentum in the US and strengthened financing in placeWe are pleased with the Q3 revenue growth in the US, where we are makin...
Invitation to presentation of Acarix´s third quarter report
Acarix will publish its third quarter results on Thursday 9 November 2023 at 08.00 am (CEST). A live webcast will be held at 14.00 (CES...
Last day of trading in paid subscribed units in Acarix’ unit rights issue is 9 November 2023
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, ...
Acarix announces final outcome in the rights issue
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, ...